AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 208 filers reported holding AMICUS THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $8,943,000 | -10.8% | 572,520 | -57.7% | 0.34% | -24.4% |
| Q3 2016 | $10,025,000 | +73.8% | 1,354,790 | +28.2% | 0.45% | +60.4% |
| Q2 2016 | $5,769,000 | -64.0% | 1,056,583 | -44.3% | 0.28% | -64.4% |
| Q1 2016 | $16,037,000 | -4.7% | 1,897,821 | +9.4% | 0.78% | -1.6% |
| Q4 2015 | $16,825,000 | +4.5% | 1,734,566 | +50.7% | 0.79% | -5.6% |
| Q3 2015 | $16,106,000 | +3.5% | 1,151,230 | +4.7% | 0.84% | +13.3% |
| Q2 2015 | $15,560,000 | +107.8% | 1,099,630 | +56.6% | 0.74% | +97.3% |
| Q1 2015 | $7,487,000 | – | 702,309 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |